21 36

Cited 0 times in

Selective omission of sentinel lymph node biopsy in mastectomy for ductal carcinoma in situ: identifying eligible candidates

Authors
 Soong June Bae  ;  Yoonwon Kook  ;  Ji Soo Jang  ;  Seung Ho Baek  ;  Sohyun Moon  ;  Jung Hyun Kim  ;  Seung Eun Lee  ;  Min Ji Kim  ;  Sung Gwe Ahn  ;  Joon Jeong 
Citation
 BREAST CANCER RESEARCH, Vol.26(1) : 65, 2024-04 
Journal Title
BREAST CANCER RESEARCH
ISSN
 1465-5411 
Issue Date
2024-04
MeSH
Breast Neoplasms* / surgery ; Carcinoma, Intraductal, Noninfiltrating* / surgery ; Female ; Humans ; Lymphatic Metastasis ; Mastectomy ; Retrospective Studies ; Sentinel Lymph Node Biopsy
Abstract
Background Sentinel lymph node biopsy (SLNB) is recommended for patients with ductal carcinoma in situ (DCIS) undergoing mastectomy, given the concerns regarding upstaging and technical difficulties of post-mastectomy SLNB. However, this may lead to potential overtreatment, considering favorable prognosis and de-escalation trends in DCIS. Data regarding upstaging and axillary lymph node metastasis among these patients remain limited. Methods We retrospectively reviewed patients with DCIS who underwent mastectomy with SLNB or axillary lymph node dissection at Gangnam Severance Hospital between January 2010 and December 2021. To explore the feasibility of omitting SLNB, we assessed the rates of DCIS upgraded to invasive carcinoma and axillary lymph node metastasis. Binary Cox regression analysis was performed to identify clinicopathologic factors associated with upstaging and axillary lymph node metastasis. Results Among 385 patients, 164 (42.6%) experienced an invasive carcinoma upgrade: microinvasion, pT1, and pT2 were confirmed in 53 (13.8%), 97 (25.2%), and 14 (3.6%) patients, respectively. Seventeen (4.4%) patients had axillary lymph node metastasis. Multivariable analysis identified age <= 50 years (adjusted odds ratio [OR], 12.73; 95% confidence interval [CI], 1.18-137.51; p = 0.036) and suspicious axillary lymph nodes on radiologic evaluation (adjusted OR, 9.31; 95% CI, 2.06-41.99; p = 0.004) as independent factors associated with axillary lymph node metastasis. Among patients aged > 50 years and/or no suspicious axillary lymph nodes, only 1.7-2.3%) experienced axillary lymph node metastasis. Conclusions Although underestimation of the invasive component was relatively high among patients with DCIS undergoing mastectomy, axillary lymph node metastasis was rare. Our findings suggest that omitting SLNB may be feasible for patients over 50 and/or without suspicious axillary lymph nodes on radiologic evaluation.
Files in This Item:
T202403095.pdf Download
DOI
10.1186/s13058-024-01816-7
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Surgery (외과학교실) > 1. Journal Papers
Yonsei Authors
Kook, Yoonwon(국윤원)
Moon, Sohyun(문소현)
Bae, Soong June(배숭준) ORCID logo https://orcid.org/0000-0002-0012-9694
Baek, Seung Ho(백승호)
Ahn, Sung Gwe(안성귀) ORCID logo https://orcid.org/0000-0002-8778-9686
Lee, Seung Eun(이승은)
Jeong, Joon(정준) ORCID logo https://orcid.org/0000-0003-0397-0005
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/199730
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links